Showing 1 - 10 of 1,437
national health economic guidelines about the inclusion or exclusion of these costs. For those studies that did include …Background:Background: When guidelines for health economic evaluations prescribe that a societal perspective should be … adopted, productivity costs should be included. However, previous research suggests that, in practice, productivity costs are …
Persistent link: https://www.econbiz.de/10011005068
Persistent link: https://www.econbiz.de/10011005069
cancer have reported only modest gains in survival. These health gains are achieved at considerable cost, but economic … the bibliographic databases PubMed, EMBASE and Health Economic Evaluations (HEED) [via the Cochrane Library] for … methodological quality of the full economic evaluations was fairly good. Transparency in costs and resource use, details on …
Persistent link: https://www.econbiz.de/10011005070
inpatients, societal costs of CF may be high. As the disease severity varies considerably among patients, costs may differ … between patients. Abstract: Objectives:Objectives: Our objectives were to calculate the average total costs of CF per patient … and per year from a societal perspective; to include all direct medical and non-medical costs as well as indirect costs …
Persistent link: https://www.econbiz.de/10011005071
Background:Background: National EQ-5D value sets are developed because preferences for health may vary in different … populations. UK values are lower than US values for most of the 243 possible EQ-5D health states. Although similar protocols were … national value sets. Participants in the UK and US studies assessed the same subset of 42 EQ-5D health states using the time …
Persistent link: https://www.econbiz.de/10011005072
economic impact of non-remission on health service use and costs over 12 months from the index episode in patients with …Background: Research has consistently demonstrated a relationship between depression and increased levels of health … health service use and cost over the 12-month study period, by remission status, where remission is defined as patients not …
Persistent link: https://www.econbiz.de/10011005073
for Belgium from a payer perspective and the results were presented as costs per QALY gained (&U20AC;, year 2009 values …
Persistent link: https://www.econbiz.de/10011005074
Introduction: Little is known regarding healthcare costs for HIV/AIDS patients in the era of highly active … dosages, tests and diagnostic procedures, outpatient visits and inpatient stays. The review used publicly available unit costs …-drug costs increased with a decreasing CD4 cell count. Conclusions: Overall, approximately half of the direct costs of HIV …
Persistent link: https://www.econbiz.de/10011005075
The design of decision-analytic models for cost-effectiveness analysis has been the subject of discussion. The current work addresses this issue by noting that, when time is to be explicitly modelled, we need to represent phenomena occurring in continuous time. Models evaluated in continuous...
Persistent link: https://www.econbiz.de/10011005076
Persistent link: https://www.econbiz.de/10011005077